Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants

• Status: Completed
• Trial end date: 2006-04-01
• Target enrollment: 0
• Participant gender: All

Summary

We hypothesize that inhaled Furosemide will be an effective treatment in infants with acute bronchiolitis.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Bnai Zion Medical Center
• Treatments: Furosemide

Criteria

Inclusion Criteria:

• Age: 0-12 months.

• Infants who are otherwise healthy

• Infants with chronic lung disease of prematurity (BPD) will be included, but will be analyzed separately.

• Parents signed a written informed consent.

Exclusion Criteria:

• • Other previous or co-morbidity, specifically: respiratory (other than BPD, like Asthma or Cystic Fibrosis), cardiac or renal disease or anomaly.